CN108403803A - A kind of compound Chinese medicinal preparation of prevention diabetic cardiovascular complications - Google Patents

A kind of compound Chinese medicinal preparation of prevention diabetic cardiovascular complications Download PDF

Info

Publication number
CN108403803A
CN108403803A CN201810246687.5A CN201810246687A CN108403803A CN 108403803 A CN108403803 A CN 108403803A CN 201810246687 A CN201810246687 A CN 201810246687A CN 108403803 A CN108403803 A CN 108403803A
Authority
CN
China
Prior art keywords
parts
raw
chinese medicinal
cardiovascular complications
diabetic cardiovascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810246687.5A
Other languages
Chinese (zh)
Other versions
CN108403803B (en
Inventor
张芯
毛竹君
胡霖霖
管家齐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Chinese Medicine University ZCMU
Original Assignee
Zhejiang Chinese Medicine University ZCMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Chinese Medicine University ZCMU filed Critical Zhejiang Chinese Medicine University ZCMU
Priority to CN201810246687.5A priority Critical patent/CN108403803B/en
Publication of CN108403803A publication Critical patent/CN108403803A/en
Application granted granted Critical
Publication of CN108403803B publication Critical patent/CN108403803B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734Crataegus (hawthorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/618Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/074Ganoderma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284Atractylodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/36Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/42Cucurbitaceae (Cucumber family)
    • A61K36/428Trichosanthes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/45Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488Pueraria (kudzu)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537Salvia (sage)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A kind of compound Chinese medicinal preparation of prevention diabetic cardiovascular complications, belongs to technical field of traditional Chinese medicines.Its by following parts by weight Chinese medicinal composition:Raw 20~40 parts of Rhizoma Atractylodis Macrocephalae, 10~30 parts of raw hawthorn, 5~25 parts of Radix Salviae Miltiorrhizae, 5~25 parts of root of Chinese trichosanthes, 20~40 parts of pueraria lobata, 20~40 parts of raw oyster, 5~25 parts of ganoderma lucidum, 5~25 parts of Snakegourd Fruit, 5~25 parts of ground bettle, 10~30 parts of Semen Vaccariae (parched), 5~25 parts of vaccini,fructus.A kind of compound Chinese medicinal preparation of above-mentioned prevention diabetic cardiovascular complications, compatibility is reasonable, has effects that transport that spleenization is turbid, blood circulation promoting and dispersing pathogen accumulation, and safety has no toxic side effect, has good effect to prevention diabetic cardiovascular complications.

Description

A kind of compound Chinese medicinal preparation of prevention diabetic cardiovascular complications
Technical field
The invention belongs to technical field of traditional Chinese medicines, and in particular to a kind of Chinese medicine compound prescription system of prevention diabetic cardiovascular complications Agent.
Background technology
Diabetes(Diabetes mellitus, DM)It is one group of metabolism characterized by chronic blood glucose levels increase Property disease, be by insulin secretion and(Or)It acts on caused by defect.Long-term carbohydrate and fat, protein metabolism are disorderly Multisystem damage can disorderly be caused, wherein diabetic cardiovascular disease change is the common complication of diabetes, and leads to patient of diabetes The main reason for person is dead.Studies have shown that with the non-diabetic patients for having myocardial infarction past medical history cardiac muscle occurs for diabetic The risk of infarct is suitable.The presence of the risk factors such as hyperglycemia and insulin resistance, can reduce nitric oxide production activity, influence blood The diastolic function of pipe, while blood vessel being stimulated to generate large amount of cell factor, promote inflammatory reaction and oxidative stress, improves Vascular permeability Property, the integrality of blood vessel endothelium is destroyed, the formation of blood vessel endothelium dysfunction is caused.In atherosclerosis (Atherosclerosis, AS)The initial stage of formation, blood vessel endothelium dysfunction still have invertibity, reverse blood vessel endothelium early Dysfunction is to inhibiting AS progress, to prevent the occurrence and development of myocardial ischemia disease to have important clinical meaning.Glycosuria Sick cardiovascular complication is a kind of disease of complexity, is related to the pathological change of more histoorgans, single control blood glucose and anti-blood Platelet aggregation etc. not can effectively prevent the occurrence and development of insulin resistance relevant blood vessel endothelial dysfunction.Traditional Chinese medicine is by the disease It is attributed to the scopes such as " diabete ", " obstruction of qi in the chest ", " palpitaition ", the present invention makees the intervention of diabetic cardiovascular complications occurrence and development With being that multi-angle is multifaceted, there is unique advantage in terms for the treatment of diabetic cardiovascular disease becomes this kind of complex disease.
Invention content
In view of the problems of the existing technology, it is an object of the invention to design a kind of prevention diabetic cardiovascular of offer simultaneously Send out the technical solution of the compound Chinese medicinal preparation of disease.
The compound Chinese medicinal preparation of a kind of prevention diabetic cardiovascular complications, it is characterised in that by following parts by weight Chinese medicinal composition:Raw 20~40 parts of Rhizoma Atractylodis Macrocephalae, 10~30 parts of raw hawthorn, 5~25 parts of Radix Salviae Miltiorrhizae, 5~25 parts of root of Chinese trichosanthes, pueraria lobata 20~40 Part, 20~40 parts of raw oyster, 5~25 parts of ganoderma lucidum, 5~25 parts of Snakegourd Fruit, 5~25 parts of ground bettle, 10~30 parts of Semen Vaccariae (parched), south 5~25 parts of principal divisor.
The compound Chinese medicinal preparation of a kind of prevention diabetic cardiovascular complications, it is characterised in that by following parts by weight Chinese medicinal composition:Raw 25~35 parts of Rhizoma Atractylodis Macrocephalae, 15~25 parts of raw hawthorn, 10~20 parts of Radix Salviae Miltiorrhizae, 10~20 parts of root of Chinese trichosanthes, pueraria lobata 25~ 35 parts, 25~35 parts of raw oyster, 10~20 parts of ganoderma lucidum, 10~20 parts of Snakegourd Fruit, 10~20 parts of ground bettle, Semen Vaccariae (parched) 15~25 Part, 10~20 parts of vaccini,fructus.
The compound Chinese medicinal preparation of a kind of prevention diabetic cardiovascular complications, it is characterised in that by following parts by weight Chinese medicinal composition:Raw 30 parts of Rhizoma Atractylodis Macrocephalae, 20 parts of raw hawthorn, 15 parts of Radix Salviae Miltiorrhizae, 15 parts of root of Chinese trichosanthes, 30 parts of pueraria lobata, 30 parts of raw oyster, ganoderma lucidum 15 parts, 15 parts of Snakegourd Fruit, 15 parts of ground bettle, 20 parts of Semen Vaccariae (parched), 15 parts of vaccini,fructus.
Raw Rhizoma Atractylodis Macrocephalae, sweet, bitter, temperature.Returns spleen, stomach.Have effects that spleen is transported in invigorating the spleen, spleen-QI transporting the essence to the whole body can be helped to fill four rushing works With, make pure and impure score, it is wet turbid not give birth to.Modern pharmacological studies have shown that raw Baizhu, which has, adjusts gastrointestinal function and hypoglycemic Effect.
Raw hawthorn, sour, sweet, tepor.Returns spleen, stomach, Liver Channel.It is warm-natured enter blood system, can pass through qi and blood, promoting blood circulation, and energy Change turbid lipid-loweringing.Modern pharmacological studies have shown that lipolytic enzyme promotes lipolysis, extract energy coronary artery dilator to increase in hawthorn Coronary blood flow, and can reducing blood lipid and antiatherosclerosis.
Radix Salviae Miltiorrhizae, it is bitter, it is slightly cold.Converge to heart and liver channels.Work(is apt to promoting blood circulation and removing blood stasis, removing blood stasis for promoting tissue regeneration, is treatment hematogenous blockage, stagnation of blood stasis Key medicine, have a title of " small four object " and among promoting circulation of blood and the energy of help.Modern pharmacological studies have shown that there is Radix Salviae Miltiorrhizae expansion to be preced with Arteries and veins increases coronary blood flow, adjusts blood fat, reduces the effect of blood viscosity, antiatherosclerosis and anti-inflammatory and antalgic.
Root of Chinese trichosanthes, sweet, slight bitter, is slightly cold.It attaches to the lung and stomach meridians.It clearing lung-heat sthenia gastropyrexia and can promote the production of body fluid to quench thirst, there is heat-clearing not Just, the characteristics of enriching yin does not hinder spleen is the key medicine for treating diabetes to wound.Modern pharmacological studies have shown that root of Chinese trichosanthes agglutinin crude product has Reduce the effect of blood glucose.
Pueraria lobata, it is sweet, pungent, it is cool.Returns spleen, stomach, lung channel.The gas of the clear sun of taste can be inspired to rise, and have the work(to promote the production of body fluid to quench thirst, Acrid flavour can manage it, the energy with clearing and activating the channels and collaterals.Modern pharmacological studies have shown that Pueraria Flavonid can expand coronary artery blood vessel and the cerebrovascular, Pueraria lobota Heterogeneity contained by root also has the effects that hypoglycemic, reducing blood lipid, anti-oxidant.
Raw oyster, it is salty, it is slightly cold.Return liver, courage, kidney channel.Have the function of checking exuberance of yang tonifying yin, increase strength and softening and resolving hard mass.It is modern Pharmacological research shows that oyster active peptides have the function of promoting islet tissue reparation and restore its secretion, and oyster extract has drop The effect of hypoglycemia.
Ganoderma lucidum, sweet and neutral.The thoughts of returning home, lung, liver and kidney channel.Energy bushing blood, invigorating heart gas, tranquilizing mind have to fill blood and do not help heat Feature.Modern pharmacological studies have shown that ganoderma lucidum can reduce blood viscosity, increase myocardial contractive power, increase coronary blood flow, ganoderma lucidum is more The adjustable glycolipid metabolism approach of sugar.
Snakegourd Fruit, it is sweet, it is slightly cold.Return lung, stomach, large intestine channel.Have the function of clearing heat and eliminating phlegm, relieving stuffiness of the chest by dispersing aggregation of pathogens, but can sharp gas open it is strongly fragrant. Modern pharmacological studies have shown that Snakegourd Fruit has expansion coronary artery, increase coronary blood flow, anticoagulation and reduction serum cholesterol etc. are a variety of Activity, it is horizontal that water extract can significantly increase hungry Rabbits ' Blood Sugar.
Ground bettle, it is salty, it trembles with fear.Return liver warp.Property is apt to walk to alter, and has the function of invigorate blood circulation dissipating bind.Modern pharmacological studies have shown that Ground bettle aqueous extract plays the role of regulating lipid metabolism, resisting oxidation free radical, protection vascular endothelial cell.
The seed of cowherb, it is bitter, it puts down.Return liver, stomach.It is good at promoting blood circulation, invigorate blood circulation dissipating bind.Modern pharmacological studies have shown that king Do not stay row can anti-angiogenesis, n-butanol extract can inhibit the proliferation of endothelial cell, migration, adherency, and Human Umbilical Vein Endothelial Cells have The clotting time can be extended after good protective effect, the seed of cowherb and Radix Salviae Miltiorrhizae compatibility, reduce whole blood viscosity.
Vaccini,fructus, acid, sweet and neutral.Return liver and kidney channel.With filling liver kidney, strengthening the bones and muscles, the effect of solid essence.Chinese medicine thinks " long Disease and kidney ", therefore shield kidney essense and QI invigorating are cared for this.
Production method:
A kind of compound Chinese medicinal preparation of prevention diabetic cardiovascular complications, the preparation is one of following dosage form:1. decoction; 2. granule;3. pill;4. capsule.The preparation by prevention diabetic cardiovascular complications herbal mixture water extract and Pharmaceutically acceptable excipients form.
The preparation is prevention diabetic cardiovascular complications decoction, the prevention diabetic cardiovascular complications decoction It is made as follows:After precise, be included in raw oyster and first boil 30min, after enter raw Rhizoma Atractylodis Macrocephalae, raw hawthorn, Radix Salviae Miltiorrhizae, root of Chinese trichosanthes, Pueraria lobata, ganoderma lucidum, Snakegourd Fruit, ground bettle, Semen Vaccariae (parched), vaccini,fructus use slow boiling instead and maintain 20min or so, will decoct after boiling by intense fire Liquid is poured out.Clear water is reentered, all drugs boil by intense fire, use slow boiling maintenance instead, pour out decocting liquid, decocting liquid will mix twice up to preventing The traditional Chinese herbal decoction of diabetic cardiovascular complications.
The preparation is prevention diabetic cardiovascular complications granule, the prevention diabetic cardiovascular complications Granula is made as follows:Precise gives birth to Rhizoma Atractylodis Macrocephalae, raw hawthorn, Radix Salviae Miltiorrhizae, root of Chinese trichosanthes, raw oyster, pueraria lobata, ganoderma lucidum, Snakegourd Fruit, soil Soft-shelled turtle worm, Semen Vaccariae (parched), vaccini,fructus, chopping or crushing appropriate set suitable for decocting in container, suitable quantity of water are added to make submergence medicinal material, After impregnating appropriate time, heating is boiled, and isolates decocting liquid after a certain period of time, and the dregs of a decoction repeat to decoct 2~3 times, collect each fried liquid, After centrifuging or settling filtration, low temperature is concentrated into normal concentration, and the medicinal extract and auxiliary material that will be condensed into certain weight proportion are mediated, necessary When be added suitable wetting agent, whole grain, the dry Chinese herbal granules to get prevention diabetic cardiovascular complications.
The preparation is prevention diabetic cardiovascular complications pill, the prevention diabetic cardiovascular complications pill It is made as follows:Precise gives birth to Rhizoma Atractylodis Macrocephalae, raw hawthorn, Radix Salviae Miltiorrhizae, root of Chinese trichosanthes, raw oyster, pueraria lobata, ganoderma lucidum, Snakegourd Fruit, ground beetle Worm, Semen Vaccariae (parched), vaccini,fructus are ground into fine powder, sieving, mixing, and refined honey closes medicine, rub ball with the hands, dry to get prevention diabetes The medicine pill of cardiovascular complication.
The preparation is prevention diabetic cardiovascular complications capsule, the prevention diabetic cardiovascular complications glue Wafer is made as follows:Precise gives birth to Rhizoma Atractylodis Macrocephalae, raw hawthorn, Radix Salviae Miltiorrhizae, root of Chinese trichosanthes, raw oyster, pueraria lobata, ganoderma lucidum, Snakegourd Fruit, soil Soft-shelled turtle worm, Semen Vaccariae (parched), vaccini,fructus, chopping or crushing appropriate set suitable for decocting in container, suitable quantity of water are added to make submergence medicinal material, After impregnating appropriate time, heating is boiled, and isolates decocting liquid after a certain period of time, and the dregs of a decoction repeat to decoct 2~3 times, collect each fried liquid, After centrifuging or settling filtration, low temperature is concentrated into normal concentration, is added or is added without pharmaceutically acceptable excipients, obtain Prevent the content of the capsule of diabetic cardiovascular complications.
A kind of compound Chinese medicinal preparation of above-mentioned prevention diabetic cardiovascular complications, compatibility is reasonable, turbid with fortune spleenization, Blood circulation promoting and dispersing pathogen accumulation effect, and safety has no toxic side effect, has good effect to prevention diabetic cardiovascular complications.
Specific implementation mode
It further illustrates the present invention with reference to embodiments.
Embodiment 1
A kind of compound Chinese medicinal preparation of prevention diabetic cardiovascular complications, by the Chinese medicinal composition of following weight:Raw Rhizoma Atractylodis Macrocephalae 30 G, 20 g of raw hawthorn, 15 g of Radix Salviae Miltiorrhizae, 15 g of root of Chinese trichosanthes, 30 g of pueraria lobata, 30 g of raw oyster, 15 g of ganoderma lucidum, 15 g of Snakegourd Fruit, ground bettle 15 g, 20 g of Semen Vaccariae (parched), vaccini,fructus 15g.
Embodiment 2
A kind of compound Chinese medicinal preparation of prevention diabetic cardiovascular complications, by the Chinese medicinal composition of following weight:Raw Rhizoma Atractylodis Macrocephalae 25 G, 15 g of raw hawthorn, 10 g of Radix Salviae Miltiorrhizae, 10 g of root of Chinese trichosanthes, 25 g of pueraria lobata, 25 g of raw oyster, 10 g of ganoderma lucidum, 10 g of Snakegourd Fruit, ground bettle 10 g, 15 g of Semen Vaccariae (parched), vaccini,fructus 10g.
Embodiment 3
A kind of compound Chinese medicinal preparation of prevention diabetic cardiovascular complications, by the Chinese medicinal composition of following weight:Raw Rhizoma Atractylodis Macrocephalae 35 G, 25 g of raw hawthorn, 20 g of Radix Salviae Miltiorrhizae, 15 g of root of Chinese trichosanthes, 35 g of pueraria lobata, 35 g of raw oyster, 20 g of ganoderma lucidum, 15 g of Snakegourd Fruit, ground bettle 15 g, 15 g of Semen Vaccariae (parched), vaccini,fructus 5g.
Embodiment 4
A kind of compound Chinese medicinal preparation of prevention diabetic cardiovascular complications, by the Chinese medicinal composition of following weight:Raw Rhizoma Atractylodis Macrocephalae 20 G, 10 g of raw hawthorn, 5 g of Radix Salviae Miltiorrhizae, 5 g of root of Chinese trichosanthes, 20 g of pueraria lobata, 20 g of raw oyster, 5 g of ganoderma lucidum, 5 g of Snakegourd Fruit, 5 g of ground bettle, 10 g of Semen Vaccariae (parched), vaccini,fructus 10g.
Embodiment 5
A kind of compound Chinese medicinal preparation of prevention diabetic cardiovascular complications, by the Chinese medicinal composition of following weight:Raw Rhizoma Atractylodis Macrocephalae 40 G, 30 g of raw hawthorn, 25 g of Radix Salviae Miltiorrhizae, 15 g of root of Chinese trichosanthes, 40 g of pueraria lobata, 40 g of raw oyster, 25 g of ganoderma lucidum, Snakegourd Fruit 15g, ground bettle 15 g, Semen Vaccariae (parched) 25g, vaccini,fructus 15g.
Test example 1
1 clinical data
1.1 general information
240 patients are the patient to go to a doctor in clinic of Zhejiang University of Traditional Chinese Medicine in January, 2016 in December, 2017, according to meter Calculation machine randomly selects number and is divided into control group and treatment group, every group each 120.Two groups of Genders, the baseline at age and the course of disease Data compares, no significant difference(P> 0.05), it is comparable.Refer to table 1.
1 two groups of patient baseline's data of table compare
1.2 diagnostic criteria
Diabetes B patient meets《Type 2 Diabetes In China guideline of prevention and treatment(Version in 2010)》Diagnostic criteria.
1.3 inclusion criteria
1. meeting above-mentioned diagnostic criteria;2. age 35-70 Sui;3. course of disease 1 year or more;4. voluntary participation simultaneously signs informed consent form Person.
1.4 exclusion criteria
1. not meeting the patient of above-mentioned diagnostic criteria and inclusion criteria;2. the severe diabetes mellitus such as ketoacidosis, diabetes are simultaneously Send out disease patient;3. merging systems serious disease and the mental patients such as angiocarpy, nerve, breathing, digestion, uropoiesis;4. I type glycosurias Disease and other secondary diabetes;5. gestation and women breast-feeding their children.
2 therapies
Control group gives doctor trained in Western medicine routine glucose-lowering treatment, and treatment group controls on the basis of control group is treated to transport that spleenization is turbid, Huoxue San " connection, It gives from quasi- activating spleen and blood circulation dissipating bind side:Raw Rhizoma Atractylodis Macrocephalae 30g, raw hawthorn 20g, Radix Salviae Miltiorrhizae 15g, root of Chinese trichosanthes 15g, pueraria lobata 30g, raw oyster 30g, Ganoderma lucidum 15g, Snakegourd Fruit 15g, ground bettle 15g, seed of cowherb 20g, vaccini,fructus 15g.Daily 1 dose, decocting 400mL, point early, evening is twice It warmly takes.The course for the treatment of is 4 weeks, and treatment carries out therapeutic evaluation after 4 weeks.Two groups of patients of tested period carry out Diabetes Mellitus Knowledge education and Diabetic diet instructs.
3 therapeutic evaluatioies
3.1 observation item
1. insulin resistance index of correlation, including fasting blood-glucose(FBG), fasting insulin(FINS)And insulin resistance index (HOMA-IR);2. vasculitic index interleukin-6(Interleukin-6, IL-6), using ELISA kits (GeneTech)Detection.
3.2 statistical tools and data processing
UsingSPSS16.0 statistical softwares, enumeration data useχ 2 It examines, measurement data usestIt examines, ranked data use order And inspection.
4 treatment results
The pretherapy and post-treatment insulin resistance index of correlation of 4.1 two groups of patients compares
Compare as can be seen from Table 2, two groups of diabetic therapy proinsulins resist index of correlation, no significant difference(P> 0.05), it is comparable.FBG, FINS, HOMA-IR improvement are superior to control group after treatment group's treatment, and difference has statistics Meaning(P<0.05), insulin resistance index of correlation, which improves, after prompting treatment group to treat is substantially better than control group.
The pretherapy and post-treatment insulin resistance index of correlation of 2 two groups of patients of table compares( ±s
Note:Compared with after control group treatment,* P< 0.05.
The pretherapy and post-treatment IL-6 levels of 4.2 two groups of patients compare
As shown in Table 3, the horizontal of IL-6 is compared before two groups of diabetic therapies, no significant difference(P> 0.05), tool There is comparativity.IL-6 levels are less than control group after treatment group's treatment, and difference has statistical significance(P< 0.05), prompt treatment Horizontal improve of IL-6 is substantially better than control group after group treatment.
The horizontal variation of 3 two groups of pretherapy and post-treatment IL-6 of patient of table( ±s, ng/L)
Note:Compared with after control group treatment,* P< 0.05.
5 discuss
Diabetic cardiovascular disease change is the common complication of diabetes, and the presence of the factors such as hyperglycemia and insulin resistance makes blood The diastolic function of pipe is impaired, and with activated endothelial cell, so that the synthesis of endothelium-derived active material is secreted and be affected, to Lead to lasting vessel retraction spasm, inflammatory reaction, platelet activation, smooth muscle cell proliferation and vascular remodeling, Atherosclerosis Change progressive exacerbation or unstable plaque rupture and myocardial infarction occurs.Traditional Chinese medicine thinks that the disease is worked as and is attributed to " diabete ", " chest The scopes such as numbness ", " palpitaition ", under physiological conditions, blood glucose, blood fat are needed by human by taste institute metaplasia from essence of water and grain Nutriment.But if eating and drinking without temperance, throw off restraint and eat greasy and surfeit flavour, or the cool drink of happiness is cold, or is hungry full variable, with the passing of time impairing the spleen and stomach, taste Transporting mistake department, then essence of water and grain be unable to metaplasia qi and blood, it is pure and impure effectively to distinguish, cause it is wet be polymerized to phlegm, in foul smell slime flux arteries and veins, this When blood in high-caliber sugar, fat become the category of phlegm wet, foul smell.It is jammed sering as phlegm is turbid, influences the operation of qi and blood, lead to gas Blood stasis is stagnant;And phlegm is turbid is reluctant to leave with the passing of time, then it can be at the card of phlegm and blood stasis.Diabetic cardiovascular disease change from the above analysis mainly relates to And two aspects, when the dysfunction of the spleen in transport, second is that phlegm and blood stasis.Therefore should spleenization is turbid, blood circulation promoting and dispersing pathogen accumulation is therapeutic rules to transport, to reach The purpose for the treatment of both manifestation and root cause of disease.The present embodiment passes through raw Rhizoma Atractylodis Macrocephalae, raw hawthorn, Radix Salviae Miltiorrhizae, root of Chinese trichosanthes, pueraria lobata, raw oyster, ganoderma lucidum, Snakegourd Fruit, soil Soft-shelled turtle worm, the seed of cowherb and day principal divisor rational proportion, by the effect of complementing each other between each component, reach fortune spleenization it is turbid, The purpose of blood circulation promoting and dispersing pathogen accumulation can effectively prevent diabetic cardiovascular complications.
It is the model case of the present invention below:
Case 1:
Lee, female, 57 years old.With diabetes medical history 3 years, metformin hydrochloride tablet, a 0.5g are taken(2), mouth 3 times a day Clothes.Recently patient feels palpitaition, and fasting blood-glucose 10.8mmol/L, very, urine is more for dry, stomach receive can, stool is viscous, a line on the 1st~2, Tongue is red, and tongue is thin white, intermittent pulse.Electrocardio illustrates frequent premature ventricular beatss.Diagnosis:Doctor trained in Western medicine diagnoses:Diabetes B frequent premature ventricular beatss Tcm diagnosis:Diabete palpitaition.The traditional Chinese herbal decoction treatment is given, further consultation palpitaition, dry, the symptoms such as viscous of defecating are apparent after 2 weeks Mitigate, fasting blood-glucose 7.5mmol/L, metformin hydrochloride tablet be kept to one time 2, take orally 2 times a day;Further consultation palpitaition, mouth after 4 weeks The symptoms such as dry disappear, and stool and urine is normal, fasting blood-glucose 7.1mmol/L, and check electrocardio illustrates the substantially normal electrocardio of sinus rhythm Figure.
Case 2:
Certain, male together, 49 years old.With diabetes medical history more than 1 year, antidiabetic drug is taken(Metformin hydrochloride tablet, repaglinide etc.), effect Fruit unobvious, fasting blood-glucose 9.2mmol/L, 140~160/90~100mmHg of blood pressure.There is precordialgia over the nearly moon, with chest Bored, thirsty, difficulty in defecation, a line on the 2nd~4, tongue is red, there is purple plague purpura, and tongue is white, veins string.Electrocardio illustrates II, III, aVF, ST sections of V2~4 It forces down.Diagnosis:Doctor trained in Western medicine diagnoses:Diabetes B coronary heart disease tcm diagnosis:Diabete chest impediment and cardialgia.Give the traditional Chinese herbal decoction Treatment, further consultation patient pectoralgia, symptom uncomfortable in chest are substantially reduced after 2 weeks, a line on the 1st of defecating, fasting blood-glucose 8.7mmol/L, blood pressure 130 ~140/85~95mmHg.Further consultation feeling of oppression and pain in the chest symptom disappears after 4 weeks, and stool and urine is normal, fasting blood-glucose 7.0mmol/L, blood pressure 130~140/80~90mmHg, electrocardio illustrate sinus rhythm, normal ECG.Turn number formulary time in locality afterwards, glycemic control is flat Surely, do not occur feeling of oppression and pain in the chest symptom again.

Claims (3)

1. a kind of compound Chinese medicinal preparation of prevention diabetic cardiovascular complications, it is characterised in that by the Chinese medicine group of following parts by weight At:Raw 20~40 parts of Rhizoma Atractylodis Macrocephalae, 10~30 parts of raw hawthorn, 5~25 parts of Radix Salviae Miltiorrhizae, 5~25 parts of root of Chinese trichosanthes, 20~40 parts of pueraria lobata, life are male 20~40 parts of oyster, 5~25 parts of ganoderma lucidum, 5~25 parts of Snakegourd Fruit, 5~25 parts of ground bettle, 10~30 parts of Semen Vaccariae (parched), vaccini,fructus 5~ 25 parts.
2. a kind of compound Chinese medicinal preparation of prevention diabetic cardiovascular complications as described in claim 1, it is characterised in that by The Chinese medicinal composition of following parts by weight:Raw 25~35 parts of Rhizoma Atractylodis Macrocephalae, 15~25 parts of raw hawthorn, 10~20 parts of Radix Salviae Miltiorrhizae, root of Chinese trichosanthes 10~20 Part, 10~20 parts of ganoderma lucidum, 10~20 parts of Snakegourd Fruit, 10~20 parts of ground bettle, fries king at 25~35 parts of pueraria lobata, 25~35 parts of raw oyster 15~25 parts of row, 10~20 parts of vaccini,fructus are not stayed.
3. a kind of compound Chinese medicinal preparation of prevention diabetic cardiovascular complications as described in claim 1, it is characterised in that by The Chinese medicinal composition of following parts by weight:Raw 30 parts of Rhizoma Atractylodis Macrocephalae, 20 parts of raw hawthorn, 15 parts of Radix Salviae Miltiorrhizae, 15 parts of root of Chinese trichosanthes, 30 parts of pueraria lobata, life are male 30 parts of oyster, 15 parts of ganoderma lucidum, 15 parts of Snakegourd Fruit, 15 parts of ground bettle, 20 parts of Semen Vaccariae (parched), 15 parts of vaccini,fructus.
CN201810246687.5A 2018-03-23 2018-03-23 Chinese medicinal compound preparation for preventing and treating cardiovascular complications of diabetes Active CN108403803B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810246687.5A CN108403803B (en) 2018-03-23 2018-03-23 Chinese medicinal compound preparation for preventing and treating cardiovascular complications of diabetes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810246687.5A CN108403803B (en) 2018-03-23 2018-03-23 Chinese medicinal compound preparation for preventing and treating cardiovascular complications of diabetes

Publications (2)

Publication Number Publication Date
CN108403803A true CN108403803A (en) 2018-08-17
CN108403803B CN108403803B (en) 2021-07-20

Family

ID=63132794

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810246687.5A Active CN108403803B (en) 2018-03-23 2018-03-23 Chinese medicinal compound preparation for preventing and treating cardiovascular complications of diabetes

Country Status (1)

Country Link
CN (1) CN108403803B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101766755A (en) * 2008-12-26 2010-07-07 北京中泰天和科技有限公司 Traditional Chinese pill for reducing blood glucose and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101766755A (en) * 2008-12-26 2010-07-07 北京中泰天和科技有限公司 Traditional Chinese pill for reducing blood glucose and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LILI WANG: "Salvia Miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases", 《CURRENT PHARMACEUTICAL DESIGN》 *
魏执真: "《名老中医魏执真心血管病经验发挥》", 30 June 2017, 北京:中国协和医科大学出版社 *
黄煜: "从脾论治糖尿病之我见 ", 《中外医疗》 *

Also Published As

Publication number Publication date
CN108403803B (en) 2021-07-20

Similar Documents

Publication Publication Date Title
CN100435831C (en) Preparation for treating high blood pressure, high blood fat, obesity, and climacteric syndrome, and preparation method
CN101716242B (en) Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases
CN103202879B (en) Traditional Chinese medicine composition for treating chronic cardiac failure and preparation method thereof
CN111729064A (en) Traditional Chinese medicine composition for invigorating spleen and activating yang and application thereof
CN101095768B (en) Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age
CN102987507B (en) Drink for patients with diabetes mellitus or constipation and preparation method thereof
CN100493572C (en) Composition of medication for treating diabetes
CN100389804C (en) &#39;Qimailing&#39; oral liquid and its preparation method
CN101306138B (en) Chinese traditional injection preparation for treating chest stuffiness and pains and its preparation method
CN104524342B (en) A kind of four drop protects the preparation method of first Chinese medicine preparation and its paste
CN100388945C (en) Fatty liver treating notoginseng prepn and its prepn process
CN101843843A (en) Chinese medicament for treating diabetes
CN102274396B (en) Traditional Chinese medicine for treating diabetic nephropathy and preparation method thereof
CN105055967B (en) A kind of complex health care product and preparation method with auxiliary hyperglycemic function
CN101628056B (en) Compound composition for treating diabetic constipation
CN1239668A (en) Oral liquid for treating cardiac and cerebral vascular diseases and promoting blood circulation and its preparation process
CN103735663A (en) Traditional Chinese medicine for reducing blood glucose and preparation method thereof
CN108403803A (en) A kind of compound Chinese medicinal preparation of prevention diabetic cardiovascular complications
CN106421559A (en) Traditional Chinese medicine preparation for curing hyperuricemia and preparation method thereof
CN106109951A (en) Prevent and treat medicine of hyperglycemia, hyperlipidemia, hypertension and preparation method thereof
CN104623499A (en) Traditional Chinese medicine preparation for assisting acupuncture treatment of diabetic gastroparesis and preparation method and applications thereof
CN103656196A (en) Traditional Chinese medicine composition for treating cutaneous pruritus caused by diabetes and preparation method thereof
CN103720931B (en) A kind of Chinese medicine composition for the treatment of damp-heat accumulation type fatty liver
CN102652822A (en) Traditional Chinese medicine oral liquid used for curing coronary heart disease
CN113384644A (en) A Chinese medicinal composition and its preparation method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant